Scilex Holding (NASDAQ:SCLXW – Get Free Report) shares were up 4.7% on Thursday . The stock traded as high as $0.22 and last traded at $0.22. Approximately 220 shares traded hands during trading, a decline of 98% from the average daily volume of 12,979 shares. The stock had previously closed at $0.21.
Scilex Price Performance
The firm has a 50-day moving average price of $0.29 and a two-hundred day moving average price of $0.32.
Scilex Company Profile
Scilex Holding Company focuses on acquiring, developing, and commercializing non-opioid pain management products for the treatment of acute and chronic pain. Its commercial products include ZTlido (lidocaine topical system) 1.8% (ZTlido), a prescription lidocaine topical product for the relief of neuropathic pain associated with postherpetic neuralgia (PHN), which is a form of post-shingles nerve pain; ELYXYB, a ready-to-use oral solution for the acute treatment of migraine with or without aura in adults; and GLOPERBA, a liquid oral version of the anti-gout medicine colchicine indicated for the prophylaxis of painful gout flares in adults.
See Also
- Five stocks we like better than Scilex
- Should You Add These Warren Buffett Stocks to Your Portfolio?
- Oil Titans Face Off: Exxon Mobil or Chevron for 2025 Gains?
- What Are Earnings Reports?
- Mining Stocks Back in the Spotlight: 3 Key Names to Watch
- 3 Home Improvement Stocks that Can Upgrade Your Portfolio
- MarketBeat Week in Review – 12/16 – 12/20
Receive News & Ratings for Scilex Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Scilex and related companies with MarketBeat.com's FREE daily email newsletter.
